Internal Medicine, Pulmonary Disease · Farmington, NM
NPI
1396940813
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
407 S Schwartz Ave Ste 202
Farmington, NM, 87401
Phone (505) 609-6770
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
884 services
Medicare patients, 2024
377
Average age 74
Drug cost, 2024
$1.2M
1,482 prescriptions
Company payments, 2025
$26.76
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph M Korah was code 99214 (office e&m - established), 381 times for 233 patients. In total Joseph M Korah billed 884 services in 13 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 381 | 233 | $89.86 | $34K |
| 94726 Pulmonary Function Testing | Facility | 121 | 121 | $8.41 | $1,018 |
| 94729 Pulmonary Function Testing | Facility | 121 | 121 | $6.28 | $760 |
| 99204 Office E&M - New | Office | 89 | 89 | $106.83 | $9,508 |
| 94010 Pulmonary Function Testing | Facility | 78 | 78 | $5.69 | $444 |
| 94060 Pulmonary Function Testing | Facility | 42 | 42 | $7.30 | $307 |
| 99213 Office E&M - Established | Office | 37 | 35 | $51.10 | $1,891 |
By year: 2022 $62K for 689 services; 2023 $53K for 731 services; 2024 $50K for 884 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph M Korah prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 315 prescriptions and refills. In total Joseph M Korah wrote 1,482 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 315 | 442 | 73 | $278K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 266 | 349 | 100 | $8,499 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 81 | 109 | 14 | $51K |
| Breo Ellipta Fluticasone/Vilanterol | 79 | 89 | 18 | $35K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 57 | 63 | Under 11 | $26K |
| Spiriva Respimat Tiotropium Bromide | 55 | 76 | 19 | $40K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 55 | 71 | 16 | $6,587 |
| Montelukast Sodium Generic | 54 | 100 | 19 | $436 |
| Roflumilast Generic | 48 | 52 | 11 | $6,217 |
| Incruse Ellipta Umeclidinium Bromide | 36 | 46 | 12 | $16K |
| Fluticasone Propionate Generic | 35 | 44 | 20 | $461 |
| Furosemide Generic | 33 | 46 | Under 11 | $134 |
| Ventolin Hfa Albuterol Sulfate | 26 | 29 | Under 11 | $1,446 |
| Opsumit Macitentan | 26 | 26 | Under 11 | $321K |
| Serevent Diskus Salmeterol Xinafoate | 21 | 33 | Under 11 | $13K |
Brand drugs: 1,046 claims; generic drugs: 436 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph M Korah $26.76 ($26.76 in general payments such as food, travel and fees) from 1 company. The largest payer was Grifols USA, LLC with $26.76.
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $26.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.